Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genetic Toxicology Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Genotoxicity Screening Assays
1.2.3 GLP Standard Genotoxicity Assays
1.3 Market by Application
1.3.1 Global Genetic Toxicology Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Mini Ames/Ames
1.3.3 Gene Mutation
1.3.4 In Vitro Micronucleus
1.3.5 Chromosome Aberration
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genetic Toxicology Market Perspective (2018-2034)
2.2 Genetic Toxicology Growth Trends by Region
2.2.1 Global Genetic Toxicology Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Genetic Toxicology Historic Market Size by Region (2018-2023)
2.2.3 Genetic Toxicology Forecasted Market Size by Region (2024-2034)
2.3 Genetic Toxicology Market Dynamics
2.3.1 Genetic Toxicology Industry Trends
2.3.2 Genetic Toxicology Market Drivers
2.3.3 Genetic Toxicology Market Challenges
2.3.4 Genetic Toxicology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genetic Toxicology Players by Revenue
3.1.1 Global Top Genetic Toxicology Players by Revenue (2018-2023)
3.1.2 Global Genetic Toxicology Revenue Market Share by Players (2018-2023)
3.2 Global Genetic Toxicology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genetic Toxicology Revenue
3.4 Global Genetic Toxicology Market Concentration Ratio
3.4.1 Global Genetic Toxicology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genetic Toxicology Revenue in 2024
3.5 Genetic Toxicology Key Players Head office and Area Served
3.6 Key Players Genetic Toxicology Product Solution and Service
3.7 Date of Enter into Genetic Toxicology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genetic Toxicology Breakdown Data by Type
4.1 Global Genetic Toxicology Historic Market Size by Type (2018-2023)
4.2 Global Genetic Toxicology Forecasted Market Size by Type (2024-2034)
5 Genetic Toxicology Breakdown Data by Application
5.1 Global Genetic Toxicology Historic Market Size by Application (2018-2023)
5.2 Global Genetic Toxicology Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Genetic Toxicology Market Size (2018-2034)
6.2 North America Genetic Toxicology Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Genetic Toxicology Market Size by Country (2018-2023)
6.4 North America Genetic Toxicology Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genetic Toxicology Market Size (2018-2034)
7.2 Europe Genetic Toxicology Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Genetic Toxicology Market Size by Country (2018-2023)
7.4 Europe Genetic Toxicology Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genetic Toxicology Market Size (2018-2034)
8.2 Asia-Pacific Genetic Toxicology Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Genetic Toxicology Market Size by Region (2018-2023)
8.4 Asia-Pacific Genetic Toxicology Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genetic Toxicology Market Size (2018-2034)
9.2 Latin America Genetic Toxicology Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Genetic Toxicology Market Size by Country (2018-2023)
9.4 Latin America Genetic Toxicology Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genetic Toxicology Market Size (2018-2034)
10.2 Middle East & Africa Genetic Toxicology Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Genetic Toxicology Market Size by Country (2018-2023)
10.4 Middle East & Africa Genetic Toxicology Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Frontage Laboratories
11.1.1 Frontage Laboratories Company Detail
11.1.2 Frontage Laboratories Business Overview
11.1.3 Frontage Laboratories Genetic Toxicology Introduction
11.1.4 Frontage Laboratories Revenue in Genetic Toxicology Business (2018-2023)
11.1.5 Frontage Laboratories Recent Development
11.2 Accelera
11.2.1 Accelera Company Detail
11.2.2 Accelera Business Overview
11.2.3 Accelera Genetic Toxicology Introduction
11.2.4 Accelera Revenue in Genetic Toxicology Business (2018-2023)
11.2.5 Accelera Recent Development
11.3 Charles River
11.3.1 Charles River Company Detail
11.3.2 Charles River Business Overview
11.3.3 Charles River Genetic Toxicology Introduction
11.3.4 Charles River Revenue in Genetic Toxicology Business (2018-2023)
11.3.5 Charles River Recent Development
11.4 Pharmaron
11.4.1 Pharmaron Company Detail
11.4.2 Pharmaron Business Overview
11.4.3 Pharmaron Genetic Toxicology Introduction
11.4.4 Pharmaron Revenue in Genetic Toxicology Business (2018-2023)
11.4.5 Pharmaron Recent Development
11.5 Labcorp
11.5.1 Labcorp Company Detail
11.5.2 Labcorp Business Overview
11.5.3 Labcorp Genetic Toxicology Introduction
11.5.4 Labcorp Revenue in Genetic Toxicology Business (2018-2023)
11.5.5 Labcorp Recent Development
11.6 Syngene
11.6.1 Syngene Company Detail
11.6.2 Syngene Business Overview
11.6.3 Syngene Genetic Toxicology Introduction
11.6.4 Syngene Revenue in Genetic Toxicology Business (2018-2023)
11.6.5 Syngene Recent Development
11.7 Vivotecnia
11.7.1 Vivotecnia Company Detail
11.7.2 Vivotecnia Business Overview
11.7.3 Vivotecnia Genetic Toxicology Introduction
11.7.4 Vivotecnia Revenue in Genetic Toxicology Business (2018-2023)
11.7.5 Vivotecnia Recent Development
11.8 Technics
11.8.1 Technics Company Detail
11.8.2 Technics Business Overview
11.8.3 Technics Genetic Toxicology Introduction
11.8.4 Technics Revenue in Genetic Toxicology Business (2018-2023)
11.8.5 Technics Recent Development
11.9 Aurigene Pharmaceutical Services
11.9.1 Aurigene Pharmaceutical Services Company Detail
11.9.2 Aurigene Pharmaceutical Services Business Overview
11.9.3 Aurigene Pharmaceutical Services Genetic Toxicology Introduction
11.9.4 Aurigene Pharmaceutical Services Revenue in Genetic Toxicology Business (2018-2023)
11.9.5 Aurigene Pharmaceutical Services Recent Development
11.10 ERBC Group
11.10.1 ERBC Group Company Detail
11.10.2 ERBC Group Business Overview
11.10.3 ERBC Group Genetic Toxicology Introduction
11.10.4 ERBC Group Revenue in Genetic Toxicology Business (2018-2023)
11.10.5 ERBC Group Recent Development
11.11 NextGen
11.11.1 NextGen Company Detail
11.11.2 NextGen Business Overview
11.11.3 NextGen Genetic Toxicology Introduction
11.11.4 NextGen Revenue in Genetic Toxicology Business (2018-2023)
11.11.5 NextGen Recent Development
11.12 Cardinal Health
11.12.1 Cardinal Health Company Detail
11.12.2 Cardinal Health Business Overview
11.12.3 Cardinal Health Genetic Toxicology Introduction
11.12.4 Cardinal Health Revenue in Genetic Toxicology Business (2018-2023)
11.12.5 Cardinal Health Recent Development
11.13 Toxys
11.13.1 Toxys Company Detail
11.13.2 Toxys Business Overview
11.13.3 Toxys Genetic Toxicology Introduction
11.13.4 Toxys Revenue in Genetic Toxicology Business (2018-2023)
11.13.5 Toxys Recent Development
11.14 Abbott Toxicology
11.14.1 Abbott Toxicology Company Detail
11.14.2 Abbott Toxicology Business Overview
11.14.3 Abbott Toxicology Genetic Toxicology Introduction
11.14.4 Abbott Toxicology Revenue in Genetic Toxicology Business (2018-2023)
11.14.5 Abbott Toxicology Recent Development
11.15 Evotec
11.15.1 Evotec Company Detail
11.15.2 Evotec Business Overview
11.15.3 Evotec Genetic Toxicology Introduction
11.15.4 Evotec Revenue in Genetic Toxicology Business (2018-2023)
11.15.5 Evotec Recent Development
11.16 EPL
11.16.1 EPL Company Detail
11.16.2 EPL Business Overview
11.16.3 EPL Genetic Toxicology Introduction
11.16.4 EPL Revenue in Genetic Toxicology Business (2018-2023)
11.16.5 EPL Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Genetic Toxicology Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Genotoxicity Screening Assays
Table 3. Key Players of GLP Standard Genotoxicity Assays
Table 4. Global Genetic Toxicology Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 5. Global Genetic Toxicology Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Genetic Toxicology Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Genetic Toxicology Market Share by Region (2018-2023)
Table 8. Global Genetic Toxicology Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Genetic Toxicology Market Share by Region (2024-2034)
Table 10. Genetic Toxicology Market Trends
Table 11. Genetic Toxicology Market Drivers
Table 12. Genetic Toxicology Market Challenges
Table 13. Genetic Toxicology Market Restraints
Table 14. Global Genetic Toxicology Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Genetic Toxicology Market Share by Players (2018-2023)
Table 16. Global Top Genetic Toxicology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Toxicology as of 2024)
Table 17. Ranking of Global Top Genetic Toxicology Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Genetic Toxicology Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Genetic Toxicology Product Solution and Service
Table 21. Date of Enter into Genetic Toxicology Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Genetic Toxicology Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Genetic Toxicology Revenue Market Share by Type (2018-2023)
Table 25. Global Genetic Toxicology Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Genetic Toxicology Revenue Market Share by Type (2024-2034)
Table 27. Global Genetic Toxicology Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Genetic Toxicology Revenue Market Share by Application (2018-2023)
Table 29. Global Genetic Toxicology Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Genetic Toxicology Revenue Market Share by Application (2024-2034)
Table 31. North America Genetic Toxicology Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 32. North America Genetic Toxicology Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Genetic Toxicology Market Size by Country (2024-2034) & (US$ Million)
Table 34. Europe Genetic Toxicology Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 35. Europe Genetic Toxicology Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Genetic Toxicology Market Size by Country (2024-2034) & (US$ Million)
Table 37. Asia-Pacific Genetic Toxicology Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 38. Asia-Pacific Genetic Toxicology Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Genetic Toxicology Market Size by Region (2024-2034) & (US$ Million)
Table 40. Latin America Genetic Toxicology Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 41. Latin America Genetic Toxicology Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Genetic Toxicology Market Size by Country (2024-2034) & (US$ Million)
Table 43. Middle East & Africa Genetic Toxicology Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. Middle East & Africa Genetic Toxicology Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Genetic Toxicology Market Size by Country (2024-2034) & (US$ Million)
Table 46. Frontage Laboratories Company Detail
Table 47. Frontage Laboratories Business Overview
Table 48. Frontage Laboratories Genetic Toxicology Product
Table 49. Frontage Laboratories Revenue in Genetic Toxicology Business (2018-2023) & (US$ Million)
Table 50. Frontage Laboratories Recent Development
Table 51. Accelera Company Detail
Table 52. Accelera Business Overview
Table 53. Accelera Genetic Toxicology Product
Table 54. Accelera Revenue in Genetic Toxicology Business (2018-2023) & (US$ Million)
Table 55. Accelera Recent Development
Table 56. Charles River Company Detail
Table 57. Charles River Business Overview
Table 58. Charles River Genetic Toxicology Product
Table 59. Charles River Revenue in Genetic Toxicology Business (2018-2023) & (US$ Million)
Table 60. Charles River Recent Development
Table 61. Pharmaron Company Detail
Table 62. Pharmaron Business Overview
Table 63. Pharmaron Genetic Toxicology Product
Table 64. Pharmaron Revenue in Genetic Toxicology Business (2018-2023) & (US$ Million)
Table 65. Pharmaron Recent Development
Table 66. Labcorp Company Detail
Table 67. Labcorp Business Overview
Table 68. Labcorp Genetic Toxicology Product
Table 69. Labcorp Revenue in Genetic Toxicology Business (2018-2023) & (US$ Million)
Table 70. Labcorp Recent Development
Table 71. Syngene Company Detail
Table 72. Syngene Business Overview
Table 73. Syngene Genetic Toxicology Product
Table 74. Syngene Revenue in Genetic Toxicology Business (2018-2023) & (US$ Million)
Table 75. Syngene Recent Development
Table 76. Vivotecnia Company Detail
Table 77. Vivotecnia Business Overview
Table 78. Vivotecnia Genetic Toxicology Product
Table 79. Vivotecnia Revenue in Genetic Toxicology Business (2018-2023) & (US$ Million)
Table 80. Vivotecnia Recent Development
Table 81. Technics Company Detail
Table 82. Technics Business Overview
Table 83. Technics Genetic Toxicology Product
Table 84. Technics Revenue in Genetic Toxicology Business (2018-2023) & (US$ Million)
Table 85. Technics Recent Development
Table 86. Aurigene Pharmaceutical Services Company Detail
Table 87. Aurigene Pharmaceutical Services Business Overview
Table 88. Aurigene Pharmaceutical Services Genetic Toxicology Product
Table 89. Aurigene Pharmaceutical Services Revenue in Genetic Toxicology Business (2018-2023) & (US$ Million)
Table 90. Aurigene Pharmaceutical Services Recent Development
Table 91. ERBC Group Company Detail
Table 92. ERBC Group Business Overview
Table 93. ERBC Group Genetic Toxicology Product
Table 94. ERBC Group Revenue in Genetic Toxicology Business (2018-2023) & (US$ Million)
Table 95. ERBC Group Recent Development
Table 96. NextGen Company Detail
Table 97. NextGen Business Overview
Table 98. NextGen Genetic Toxicology Product
Table 99. NextGen Revenue in Genetic Toxicology Business (2018-2023) & (US$ Million)
Table 100. NextGen Recent Development
Table 101. Cardinal Health Company Detail
Table 102. Cardinal Health Business Overview
Table 103. Cardinal Health Genetic Toxicology Product
Table 104. Cardinal Health Revenue in Genetic Toxicology Business (2018-2023) & (US$ Million)
Table 105. Cardinal Health Recent Development
Table 106. Toxys Company Detail
Table 107. Toxys Business Overview
Table 108. Toxys Genetic Toxicology Product
Table 109. Toxys Revenue in Genetic Toxicology Business (2018-2023) & (US$ Million)
Table 110. Toxys Recent Development
Table 111. Abbott Toxicology Company Detail
Table 112. Abbott Toxicology Business Overview
Table 113. Abbott Toxicology Genetic Toxicology Product
Table 114. Abbott Toxicology Revenue in Genetic Toxicology Business (2018-2023) & (US$ Million)
Table 115. Abbott Toxicology Recent Development
Table 116. Evotec Company Detail
Table 117. Evotec Business Overview
Table 118. Evotec Genetic Toxicology Product
Table 119. Evotec Revenue in Genetic Toxicology Business (2018-2023) & (US$ Million)
Table 120. Evotec Recent Development
Table 121. EPL Company Detail
Table 122. EPL Business Overview
Table 123. EPL Genetic Toxicology Product
Table 124. EPL Revenue in Genetic Toxicology Business (2018-2023) & (US$ Million)
Table 125. EPL Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genetic Toxicology Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global Genetic Toxicology Market Share by Type: 2024 VS 2034
Figure 3. Genotoxicity Screening Assays Features
Figure 4. GLP Standard Genotoxicity Assays Features
Figure 5. Global Genetic Toxicology Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 6. Global Genetic Toxicology Market Share by Application: 2024 VS 2034
Figure 7. Mini Ames/Ames Case Studies
Figure 8. Gene Mutation Case Studies
Figure 9. In Vitro Micronucleus Case Studies
Figure 10. Chromosome Aberration Case Studies
Figure 11. Others Case Studies
Figure 12. Genetic Toxicology Report Years Considered
Figure 13. Global Genetic Toxicology Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 14. Global Genetic Toxicology Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 15. Global Genetic Toxicology Market Share by Region: 2024 VS 2034
Figure 16. Global Genetic Toxicology Market Share by Players in 2024
Figure 17. Global Top Genetic Toxicology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Toxicology as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Genetic Toxicology Revenue in 2024
Figure 19. North America Genetic Toxicology Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. North America Genetic Toxicology Market Share by Country (2018-2034)
Figure 21. United States Genetic Toxicology Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Canada Genetic Toxicology Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Genetic Toxicology Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe Genetic Toxicology Market Share by Country (2018-2034)
Figure 25. Germany Genetic Toxicology Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. France Genetic Toxicology Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. U.K. Genetic Toxicology Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Italy Genetic Toxicology Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Russia Genetic Toxicology Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Nordic Countries Genetic Toxicology Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Genetic Toxicology Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Asia-Pacific Genetic Toxicology Market Share by Region (2018-2034)
Figure 33. China Genetic Toxicology Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Japan Genetic Toxicology Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. South Korea Genetic Toxicology Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Southeast Asia Genetic Toxicology Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. India Genetic Toxicology Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Australia Genetic Toxicology Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Genetic Toxicology Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Latin America Genetic Toxicology Market Share by Country (2018-2034)
Figure 41. Mexico Genetic Toxicology Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Brazil Genetic Toxicology Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Genetic Toxicology Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Middle East & Africa Genetic Toxicology Market Share by Country (2018-2034)
Figure 45. Turkey Genetic Toxicology Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Saudi Arabia Genetic Toxicology Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Frontage Laboratories Revenue Growth Rate in Genetic Toxicology Business (2018-2023)
Figure 48. Accelera Revenue Growth Rate in Genetic Toxicology Business (2018-2023)
Figure 49. Charles River Revenue Growth Rate in Genetic Toxicology Business (2018-2023)
Figure 50. Pharmaron Revenue Growth Rate in Genetic Toxicology Business (2018-2023)
Figure 51. Labcorp Revenue Growth Rate in Genetic Toxicology Business (2018-2023)
Figure 52. Syngene Revenue Growth Rate in Genetic Toxicology Business (2018-2023)
Figure 53. Vivotecnia Revenue Growth Rate in Genetic Toxicology Business (2018-2023)
Figure 54. Technics Revenue Growth Rate in Genetic Toxicology Business (2018-2023)
Figure 55. Aurigene Pharmaceutical Services Revenue Growth Rate in Genetic Toxicology Business (2018-2023)
Figure 56. ERBC Group Revenue Growth Rate in Genetic Toxicology Business (2018-2023)
Figure 57. NextGen Revenue Growth Rate in Genetic Toxicology Business (2018-2023)
Figure 58. Cardinal Health Revenue Growth Rate in Genetic Toxicology Business (2018-2023)
Figure 59. Toxys Revenue Growth Rate in Genetic Toxicology Business (2018-2023)
Figure 60. Abbott Toxicology Revenue Growth Rate in Genetic Toxicology Business (2018-2023)
Figure 61. Evotec Revenue Growth Rate in Genetic Toxicology Business (2018-2023)
Figure 62. EPL Revenue Growth Rate in Genetic Toxicology Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed